MeVis Medical Solutions AG / Key word(s): Change in Forecast
MeVis Medical Solutions AG: Raising forecast for the current fiscal year

30-Aug-2018 / 15:51 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Bremen, August 30, 2018 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, raises its forecast for the present fiscal year due to the positive business development:

For fiscal year 2018 (October 1, 2017 to September 30, 2018) a significant decrease in revenues to EUR 16.0 million to EUR 16.5 million is now expected (previous forecast for fiscal year 2018: significant decrease to EUR 14.5 million to EUR 15.0 million).
For fiscal year 2018 (October 1, 2017 to September 30, 2018) a significant decrease in the EBIT (earnings before interest and taxes) is expected to EUR 5.5 million to EUR 6.0 million (previous forecast for fiscal year 2018: decrease in EBIT to EUR 3.0 million to EUR 3.5 million).

************************************************************************

Contact:

Dr. Hannemann, Robert / CFO

30-Aug-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone:	+49 421 224 95 0
Fax:	+49 421 224 95 999
E-mail:	ir@mevis.de
Internet:	http://www.mevis.de
ISIN:	DE000A0LBFE4
WKN:	A0LBFE
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange

MeVis Medical Solutions AG: Raising forecast for the current fiscal year

More From BioPortfolio on "MeVis Medical Solutions AG: Raising forecast for the current fiscal year"